| __timestamp | Ionis Pharmaceuticals, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 79838000 |
| Thursday, January 1, 2015 | 322292000 | 121816000 |
| Friday, January 1, 2016 | 344320000 | 117633000 |
| Sunday, January 1, 2017 | 374644000 | 4577000 |
| Monday, January 1, 2018 | 1820000 | 12670000 |
| Tuesday, January 1, 2019 | 4000000 | 12135000 |
| Wednesday, January 1, 2020 | 12000000 | 18942000 |
| Friday, January 1, 2021 | 11000000 | 32328000 |
| Saturday, January 1, 2022 | 14000000 | 44678000 |
| Sunday, January 1, 2023 | 9133000 | 65486000 |
Data in motion
In the competitive world of biotechnology, understanding cost dynamics is crucial. Ionis Pharmaceuticals, Inc. and PTC Therapeutics, Inc. have shown contrasting trends in their cost of revenue from 2014 to 2023. Ionis Pharmaceuticals experienced a significant decline in costs, dropping from a peak in 2017 to a mere 9% of that value by 2023. This reduction reflects strategic cost management and possibly a shift in operational focus. Conversely, PTC Therapeutics saw a steady increase, with costs rising by over 700% from 2017 to 2023. This surge could indicate expansion efforts or increased production activities. These trends highlight the diverse strategies employed by biotech firms to navigate the financial landscape, offering valuable insights for investors and industry analysts alike.
Cost of Revenue Trends: Pfizer Inc. vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Ionis Pharmaceuticals, Inc.
Cost of Revenue Trends: United Therapeutics Corporation vs PTC Therapeutics, Inc.
Viatris Inc. vs Ionis Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Halozyme Therapeutics, Inc. and PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Cytokinetics, Incorporated vs Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Ionis Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Comparing Cost of Revenue Efficiency: Ionis Pharmaceuticals, Inc. vs Ligand Pharmaceuticals Incorporated
Ionis Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down PTC Therapeutics, Inc. and Perrigo Company plc's Expenses
PTC Therapeutics, Inc. vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for PTC Therapeutics, Inc. and Dyne Therapeutics, Inc.